BACKGROUND: Because the diagnosis of attention deficit hyperactivity disorder (ADHD) in higher education settings is rapidly becoming a contentious issue, particularly among patients with high IQs, we sought to assess the validity of diagnosing ADHD in high-IQ adults and to further characterize the clinical features associated with their ADHD. METHOD: We operationalized high IQ as having a full-scale IQ120. We identified 53 adults with a high IQ who did not have ADHD and 64 adults with a high IQ who met diagnostic criteria for ADHD. Groups did not differ on IQ, socio-economic status or gender. RESULTS: High-IQ adults with ADHD reported a lower quality of life, had poorer familial and occupational functioning, and had more functional impairments, including more speeding tickets, accidents and arrests. Major depressive disorder, obsessive-compulsive disorder and generalized anxiety disorder diagnoses were higher in high-IQ adults with ADHD. All other psychiatric co-morbidities, including antisocial personality disorder and substance abuse, did not differ between the two high-IQ groups. ADHD was more prevalent in first-degree relatives of adults with ADHD relative to controls. CONCLUSIONS: Our data suggest that adults with ADHD and a high IQ display patterns of functional impairments, familiality and psychiatric co-morbidities that parallel those found in the average-IQ adult ADHD population.
BACKGROUND: Because the diagnosis of attention deficit hyperactivity disorder (ADHD) in higher education settings is rapidly becoming a contentious issue, particularly among patients with high IQs, we sought to assess the validity of diagnosing ADHD in high-IQ adults and to further characterize the clinical features associated with their ADHD. METHOD: We operationalized high IQ as having a full-scale IQ120. We identified 53 adults with a high IQ who did not have ADHD and 64 adults with a high IQ who met diagnostic criteria for ADHD. Groups did not differ on IQ, socio-economic status or gender. RESULTS: High-IQ adults with ADHD reported a lower quality of life, had poorer familial and occupational functioning, and had more functional impairments, including more speeding tickets, accidents and arrests. Major depressive disorder, obsessive-compulsive disorder and generalized anxiety disorder diagnoses were higher in high-IQ adults with ADHD. All other psychiatric co-morbidities, including antisocial personality disorder and substance abuse, did not differ between the two high-IQ groups. ADHD was more prevalent in first-degree relatives of adults with ADHD relative to controls. CONCLUSIONS: Our data suggest that adults with ADHD and a high IQ display patterns of functional impairments, familiality and psychiatric co-morbidities that parallel those found in the average-IQ adult ADHD population.
Authors: Larry J Seidman; Joseph Biederman; Lichen Liang; Eve M Valera; Michael C Monuteaux; Ariel Brown; Jonathan Kaiser; Thomas Spencer; Stephen V Faraone; Nikos Makris Journal: Biol Psychiatry Date: 2010-12-23 Impact factor: 13.382
Authors: Marijn A Distel; Angela Carlier; Christel M Middeldorp; Catherine A Derom; Gitta H Lubke; Dorret I Boomsma Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2011-08-02 Impact factor: 3.568
Authors: Alexander A Stevens; Leeza Maron; Joel T Nigg; Desmond Cheung; Edward F Ester; Edward Awh Journal: J Int Neuropsychol Soc Date: 2012-03-20 Impact factor: 2.892
Authors: Joseph Biederman; Leah Feinberg; James Chan; Bamidele O Adeyemo; K Yvonne Woodworth; Walter Panis; Neal McGrath; Saurabha Bhatnagar; Thomas J Spencer; Mai Uchida; Tara Kenworthy; Rebecca Grossman; Ross Zafonte; Stephen V Faraone Journal: J Nerv Ment Dis Date: 2015-11 Impact factor: 2.254
Authors: Dorret I Boomsma; Viatcheslav Saviouk; Jouke-Jan Hottenga; Marijn A Distel; Marleen H M de Moor; Jacqueline M Vink; Lot M Geels; Jenny H D A van Beek; Meike Bartels; Eco J C de Geus; Gonneke Willemsen Journal: PLoS One Date: 2010-05-12 Impact factor: 3.240
Authors: Sandra J J Kooij; Susanne Bejerot; Andrew Blackwell; Herve Caci; Miquel Casas-Brugué; Pieter J Carpentier; Dan Edvinsson; John Fayyad; Karin Foeken; Michael Fitzgerald; Veronique Gaillac; Ylva Ginsberg; Chantal Henry; Johanna Krause; Michael B Lensing; Iris Manor; Helmut Niederhofer; Carlos Nunes-Filipe; Martin D Ohlmeier; Pierre Oswald; Stefano Pallanti; Artemios Pehlivanidis; Josep A Ramos-Quiroga; Maria Rastam; Doris Ryffel-Rawak; Steven Stes; Philip Asherson Journal: BMC Psychiatry Date: 2010-09-03 Impact factor: 3.630
Authors: J R Valdizán-Usón; A Cánovas-Martínez; M T De Lucas-Taracena; F Díaz-Atienza; L S Eddy-Ives; A Fernández-Jaén; M Fernández-Pérez; M García-Giral; P García-Magán; M Garraus-Oneca; M A Idiazábal-Alecha; M López-Benito; G Lorenzo-Sanz; J Martínez-Antón; M A Martínez-Granero; F Montañés-Rada; F Mulas-Delgado; G Ochando-Perales; E Ortega-García; A Pelaz-Antolín; J A Ramos-Quiroga; F C Ruiz-Sanz; J Vaquerizo-Madrid; A Yusta-Izquierdo Journal: Neuropsychiatr Dis Treat Date: 2013-02-08 Impact factor: 2.570
Authors: Paul Hodgkins; L Eugene Arnold; Monica Shaw; Hervé Caci; Jennifer Kahle; Alisa G Woods; Susan Young Journal: Front Psychiatry Date: 2012-01-18 Impact factor: 4.157